Concepedia

Aaron L. Magno

AL

16

Publications

1.2K

Citations

15

H-Index

2004

Active since

Affiliations

The University of Western Australia(Current)

Sir Charles Gairdner Hospital

Lions Eye Institute

Royal Perth Hospital

Harry Perkins Institute of Medical Research

Aaron L. Magno is an author at The University of Western Australia specializing in medicine, ophthalmology, and physiology.

ORCID

Top concepts

Publications per year

2004–2020

16

Publications

16

SGLT2 Inhibitor–Induced Sympathoinhibition

Lakshini Y. Herat, Aaron L. Magno, Caroline Rudnicka et al. · JACC Basic to Translational Science · 2020 · 227 citations · Full text

, , +20

Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial

Elizabeth Rakoczy, Chooi‐May Lai, Aaron L. Magno et al. · The Lancet · 2015 · 182 citations · Full text

, , +12

Phase 2a Randomized Clinical Trial: Safety and Post Hoc Analysis of Subretinal rAAV.sFLT-1 for Wet Age-related Macular Degeneration

Ian J. Constable, Cora Pierce, Chooi‐May Lai et al. · EBioMedicine · 2016 · 150 citations · Full text

Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial

Erin A. Bohula, Benjamin M. Scirica, Silvio E. Inzucchi et al. · The Lancet · 2018 · 94 citations · Full text

, , +9

Molecular analysis of blood–retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy

Joanna Wisniewska‐Kruk, Ingeborg Klaassen, Ilse M. C. Vogels et al. · Experimental Eye Research · 2014 · 74 citations

, , +11

Rows per page

1–5 of 16